Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan.

Liver transplantation for patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) remains challenging. The advent of highly active antiretroviral therapy (HAART) for HIV has reduced mortality from opportunistic infection related to acquired immunodeficiency syndrome dramatically, while about 50% of patients die of end-stage liver cirrhosis resulting from HCV. In Japan, liver cirrhosis frequently develops after HCV-HIV coinfection resulting from previously transfused infected blood products for hemophilia. The problems of liver transplantation for those patients arise from the need to control calcineurin inhibitor with HAART drugs, the difficulty of using interferon after liver transplantation with HAART, and the need to control intraoperative coagulopathy associated with hemophilia. We review published reports of liver transplantation for these patients in the updated world literature

Tamsulosin-induced acute liver injury: a case report

International audienceMeeting Abstract: PS-052, 20e congrès de la Société Française de Pharmacologie et de Thérapeutique, Nancy, 19-21 avril 201

Brand-name to generic substitution of antiepileptic Drugs (AED) does not lead to seizure-related hospitalization: a Population-based case-crossover study

International audienceno abstrac

Incidence of pregnancy in women with multiple sclerosis treated with teriflunomide in France

International audienc

Vigilance of clinical trials: Retrospective analysis of working time and associated costs for a completed study

International audienceMeeting Abstract PS-08